Location of Repository

Modelling alternative strategies for delivering hepatitis B\ud vaccine in prisons : the impact on the vaccination coverage of the injecting drug user population

By A. J. Sutton, N. J. Gay, W. John Edmunds and O. N. Gill

Abstract

Since 2001 hepatitis B vaccination has been offered to prisoners on reception into prisons in\ud England and Wales. However, short campaigns of vaccinating the entire population of individual\ud prisons have achieved high vaccination coverage for limited periods, suggesting that short\ud campaigns may be a preferable way of vaccinating prisoners. A model is used that describes the\ud flow of prisoners through prisons stratified by injecting status to compare a range of vaccination\ud scenarios that describe vaccination on prison reception or via regular short campaigns. Model\ud results suggest that vaccinating on prison reception can capture a greater proportion of the\ud injecting drug user (IDU) population than the comparable campaign scenarios (63% vs. 55 . 6%\ud respectively). Vaccination on prison reception is also more efficient at capturing IDUs for\ud vaccination than vaccination via a campaign, although vaccination via campaigns may have a\ud role with some infections for overall control

Topics: RA
Publisher: Cambridge University Press
Year: 2008
OAI identifier: oai:wrap.warwick.ac.uk:3199

Suggested articles

Preview

Citations

  1. (2005). Agency, Health Protection Scotland, National Public Health Service for Wales, CDSC Northern Ireland, CRDHB, and UASSG. Shooting up; infections among injecting drug users in the United Kingdom 2004: an update,
  2. (2006). Health Protection Agency (www.hpa.org.uk). Accessed
  3. (2000). Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a National Survey. Communicable Disease and Public Health
  4. (2006). Modelling the hepatitis B vaccination programme in prisons. Epidemiology and Infection doi
  5. (1997). Anonymous HIV surveillance with risk-factor elicitation: at Perth (for men) and Cornton Vale (for women) prisons in Scotland. doi
  6. (2000). Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. doi
  7. (2005). Vaccination in the county jail as a strategy to reach high risk adults during a community-based hepatitis a outbreak among methamphetamine drug users. Vaccine doi
  8. (2004). Hepatitis A vaccination – a prisonbased solution for a community-based outbreak? Communicable Disease and Public Health
  9. (2004). Increasing hepatitis B vaccine coverage in prisons in England and Wales. Communicable Disease and Public Health
  10. (2004). Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons. Vaccine doi
  11. (2006). Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales. Vaccine doi
  12. (2005). and HIV in correctional populations: a review of epidemiology and prevention. AIDS doi
  13. (1995). Anonymous HIV surveillance with risk factor elicitation at Scotland’s largest prison, Barlinnie. AIDS doi
  14. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.